Head Finance Development |
Milano |
Italy |
Finance |
Innovative Medicines |
Audit & Finance |
Nov 15, 2024 |
Embrace Advisor Verona |
Field Force (Italy) |
Italy |
International |
Innovative Medicines |
Others |
Nov 13, 2024 |
Capability Building Manager |
Milano |
Italy |
International |
Innovative Medicines |
Sales |
Nov 13, 2024 |
QC Analyst |
Ivrea |
Italy |
International |
Innovative Medicines |
Quality |
Nov 11, 2024 |
Clinical Research Associate |
Field Force (Italy) |
Italy |
Development |
Innovative Medicines |
Research & Development |
Nov 08, 2024 |
Tender activities manager |
Milano |
Italy |
Operations |
Innovative Medicines |
Sales |
Nov 07, 2024 |
Site Quality Head Strategic / Large Site |
Torre Annunziata |
Italy |
Operations |
Innovative Medicines |
Quality |
Nov 04, 2024 |
Qualification Expert (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Okt 24, 2024 |
Manutentore Meccanico/Elettrico |
Torre Annunziata |
Italy |
Operations |
Innovative Medicines |
Technical Operations |
Okt 24, 2024 |
Quality Assurance Specialist |
Milano |
Italy |
Operations |
Innovative Medicines |
Quality |
Okt 23, 2024 |
Process Expert |
Saluggia |
Italy |
Operations |
Innovative Medicines |
Technical Operations |
Okt 21, 2024 |
Specialist, Operations ITOT Automation Engineer |
Ivrea |
Italy |
Operations |
Innovative Medicines |
Technical Operations |
Okt 15, 2024 |
QC Senior Scientist |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Okt 14, 2024 |
Automation Engineer, Senior Specialist |
Ivrea |
Italy |
Operations |
Innovative Medicines |
Technical Operations |
Okt 10, 2024 |
RLT Formulation Project Leader |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Sep 03, 2024 |
RLT Analytical Product Project Leader (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Juli 11, 2024 |
RLT Drug Product Project Lead (m/f/d) |
Ivrea |
Italy |
International |
Innovative Medicines |
Research & Development |
Juli 11, 2024 |